← Back to Search

NA

Messaging Strategies for Vaccine Hesitancy

N/A
Waitlist Available
Led By Carl A Latkin, Ph.D.
Research Sponsored by Johns Hopkins Bloomberg School of Public Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

This trial will develop and test interventions to encourage people to talk to each other about COVID-19 vaccination and climate change.

Who is the study for?
This trial is for U.S. residents over 18 who speak and read English, are aware of COVID-19 and the vaccine, and have a history of quality responses on Prolific's platform. Participants must consent to join.Check my eligibility
What is being tested?
The study is testing peer communication strategies aimed at educating others about COVID-19 vaccination and climate change issues through social diffusion interventions.See study design
What are the potential side effects?
Since this trial involves messaging strategies rather than medical interventions, there are no direct physical side effects. However, participants may experience stress or discomfort discussing sensitive topics.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Actions to promote climate change activism in social network
Actions to promote vaccine uptake in social network
Frequency of conversations about climate change
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: vaccineExperimental Treatment1 Intervention
Promotes COVID-19 vaccine uptake
Group II: climate changeActive Control1 Intervention
Promotes climate change activism
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Social diffusion intervention
2022
N/A
~600

Find a Location

Who is running the clinical trial?

Johns Hopkins Bloomberg School of Public HealthLead Sponsor
411 Previous Clinical Trials
2,107,039 Total Patients Enrolled
1 Trials studying Vaccine Hesitancy
2,058 Patients Enrolled for Vaccine Hesitancy
Carl A Latkin, Ph.D.Principal InvestigatorJohns Hopkins Bloomberg School of Public Health
1 Previous Clinical Trials
240 Total Patients Enrolled

Media Library

Social diffusion intervention (NA) Clinical Trial Eligibility Overview. Trial Name: NCT05530044 — N/A
Vaccine Hesitancy Research Study Groups: vaccine, climate change
Vaccine Hesitancy Clinical Trial 2023: Social diffusion intervention Highlights & Side Effects. Trial Name: NCT05530044 — N/A
Social diffusion intervention (NA) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05530044 — N/A
~218 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top